The Rasmuson Foundation: Supporting Alaskans and Supporting Research
Benaroya Research Institute sincerely thanks the Rasmuson Foundation of Anchorage, Alaska, for providing a $1 million grant to bring education and access to clinical trials to Alaskans suffering from autoimmune diseases, cancer and many other conditions.
- The grant enrolled a total of 87 Alaskans into clinical trials.
- They joined more than 30 different clinical trials for diseases including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, scleroderma, hepatitis and many types of cancer.
- Many of these patients graciously donated blood and tissue samples for the BRI biorepositories to help advance research.
- Alaskan study participants increased the understanding and treatment for a variety of diseases. For example, multiple Alaskans were enrolled onto a hepatitis C trial for a drug called Boceprevir. Based on this research, the drug has been approved by the FDA and is now the standard of care for treating hepatitis C.
- The grant provided participants with 431 round-trip visits to Seattle from Hoonah to Fairbanks and numerous cities in between.
- BRI and Virginia Mason staff provided health information to the state by talking with clinicians and attending health fairs and conferences.
You Might Also Like
Innovation Fund Spotlight: New Tool Enables Scientists to Collect More Data From Rare Cells
Scientists know that cells of the immune system attack healthy tissue in autoimmune disease. But they don’t know exactly when those cells go awry, what drives them toward disease or if that process can be slowed or stopped to prevent disease. BRI has been instrumental in research that led to the first medicine to delay the onset of type 1 diabetes. Now, Peter Morawski, PhD, and Arpit Mishra, PhD, are building on that work and exploring early intervention in other autoimmune diseases.
Innovation Fund Spotlight: Finding the Precise Moment When Immune Cells Start Causing Disease
Autoimmune diseases happen when immune cells, which are supposed to protect you from germs, mistakenly attack healthy tissues. But what if we knew exactly which immune cells would attack – and when? Could we stop that attack before it starts? BRI’s John Ray, PhD, and Oliver Harrison, DPhil, are exploring exactly that.
How Does Wildfire Smoke Impact the Immune System?
As wildfire smoke becomes more common in the Pacific Northwest, BRI scientists are learning more about how it influences immune system function. We asked Dr. Megan Smithmyer about her research in this area and a new study examining the immune systems of wildland firefighters.
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.